Analysis of Circulating Microvesicles Levels and Effects of Associated Factors in Elderly Patients With Obstructive

Jin Tan1, Huifang Xing1, Sha Sha1

  • 1Department of Geriatrics, Tianjin Medical University General Hospital, Tianjin Geriatrics Institute, Tianjin, China.

Insights

Circulating microvesicles (MVs) are elevated in elderly patients with obstructive sleep apnea (OSA) and correlate with OSA severity and obesity. Further studies are needed to confirm the impact of age and comorbidities on MV levels in older adults with OSA.

Area of Science:

  • Cardiovascular Research
  • Sleep Medicine
  • Biomarker Discovery

Background:

  • Obstructive sleep apnea (OSA) is prevalent in the elderly and linked to chronic diseases.
  • Microvesicles (MVs) are implicated in OSA pathogenesis, but their levels in elderly OSA patients are unknown.
  • Understanding MV concentrations is crucial for assessing OSA-related health risks in older adults.

Purpose of the Study:

  • To quantify circulating microvesicle (MV) concentrations in elderly patients with obstructive sleep apnea (OSA).
  • To investigate the association between MV levels and OSA severity, obesity, age, and comorbidities.
  • To explore the influence of different labeling methods on MV measurements.

Main Methods:

  • Recruited patients over 60 years old undergoing polysomnography.
  • Measured plasma MV concentrations (annexin V+, EMVs, PMVs, LMVs) using flow cytometry with various labels.
  • Analyzed correlations between MV levels and OSA severity, obesity, age, and comorbidities using Spearman correlation and multiple linear regression.

Main Results:

  • Elevated levels of single- and dual-labeled circulating MVs were observed in elderly OSA patients.
  • Circulating MV concentrations positively correlated with OSA severity (AHI, ODI, SPO2min).
  • Obesity showed a significant effect on MV concentrations; age and comorbidities had non-significant correlations.

Conclusions:

  • Circulating MV concentrations in elderly OSA patients are linked to the labeling method, OSA severity, and obesity.
  • The influence of age and comorbidities on MV levels requires further investigation with larger sample sizes.
  • This study highlights MVs as potential biomarkers in elderly OSA.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
288
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
206
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
62